Patient Worthy

10 hours ago

Rheumatoid Arthritis Awareness Day is observed on February 2 each year to spread awareness about this chronic autoimmune disease.
RA causes joint pain, swelling, and can also affect organs such as the heart and lungs.
Established by the Rheumatoid Patient Foundation in 2013, this day highlights the importance of early diagnosis and better understanding of RA.
Let’s support those living with RA by learning the symptoms and sharing awareness.
#RAAwareness #RheumatoidArthritisAwarenessDay #PatientWorthy ... See MoreSee Less

Patient Worthy

12 hours ago

#stargartdisease #clinicaltrial @FoundationFightingBlindnessA new clinical trial is now enrolling for individuals with ABCA4-related Stargardt disease.

The CELESTE Study, sponsored by AAVantgarde Bio, is a first-in-human Phase 1/2 clinical trial evaluating an investigational gene therapy designed to address the genetic cause of Stargardt disease—with the goal of slowing or halting vision loss.

The study is recruiting eligible participants ages 8–55 at select sites in the U.S., U.K., and Europe.

Learn more by contacting: [email protected], or please visit ClinicalTrials.gov

Image Description: Dark blue background with the Foundation Fighting Blindness logo at the top, with text below in green that says "Partner News." Below that is the text "New clinical trial for ABCA4-related Stargardt disease," followed by the AAVantgarde Bio logo. ... See MoreSee Less